PET studies of net blood-brain clearance of FDOPA to human brain: Age-dependent decline of [18F]fluorodopamine storage capacity

Yoshitaka Kumakura, Ingo Vernaleken, Gerhard Gründer, Peter Bartenstein, Albert Gjedde, Paul Gumming

Research output: Contribution to journalArticle

Abstract

Conventional methods for the graphical analysis of 6-[18F] fluorodopa (FDOPA)/positron emission tomography (PET) recordings (K inapp) may be prone to negative bias because of oversubtraction of the precursor pool in the region of interest, and because of diffusion of decarboxylated FDOPA metabolites from the brain. These effects may reduce the sensitivity of FDOPA/PET for the detection of age-related changes in dopamine innervations. To test for these biasing effects, we have used a constrained compartmental analysis to calculate the brain concentrations of the plasma metabolite 3-O-methyl-FDOPA (OMFD) during 120 mins of FDOPA circulation in healthy young, healthy elderly, and Parkinson's disease subjects. Calculated brain OMFD concentrations were subtracted frame-by-frame from the dynamic PET recordings, and maps of the FDOPA net influx to brain were calculated assuming irreversible trapping (Kapp). Comparison of Kin app and Kapp maps revealed a global negative bias in the conventional estimates of FDOPA clearance. The present OMFD subtraction method revealed curvature in plots of Kapp at early times, making possible the calculation of the corrected net influx (K) and also the rate constant for diffusion of decarboxylated metabolites from the brain (kloss). The effective distribution volume (EDV2; K/kloss) for FDOPA, an index of dopamine storage capacity in brain, was reduced by 85% in putamen of patients with Parkinson's disease, and by 58% in the healthy elderly relative to the healthy young control subjects. Results of the present study support claims that storage capacity for dopamine in both caudate and putamen is more profoundly impaired in patients with Parkinson's disease than is the capacity for DOPA utilization, calculated by conventional FDOPA net influx plots. The present results furthermore constitute the first demonstration of an abnormality in the cerebral utilization of FDOPA in caudate and putamen as a function of normal aging, which we attribute to loss of vesicular storage capacity.

Original languageEnglish (US)
Pages (from-to)807-819
Number of pages13
JournalJournal of Cerebral Blood Flow and Metabolism
Volume25
Issue number7
DOIs
StatePublished - 2005
Externally publishedYes

Fingerprint

Positron-Emission Tomography
Brain
Putamen
Parkinson Disease
Dopamine
fluorodopa F 18

Keywords

  • [F]fluorodopa
  • Compartmental analysis
  • Net influx
  • Parametric mapping
  • PET

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)
  • Endocrinology, Diabetes and Metabolism

Cite this

PET studies of net blood-brain clearance of FDOPA to human brain : Age-dependent decline of [18F]fluorodopamine storage capacity. / Kumakura, Yoshitaka; Vernaleken, Ingo; Gründer, Gerhard; Bartenstein, Peter; Gjedde, Albert; Gumming, Paul.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 25, No. 7, 2005, p. 807-819.

Research output: Contribution to journalArticle

Kumakura, Yoshitaka ; Vernaleken, Ingo ; Gründer, Gerhard ; Bartenstein, Peter ; Gjedde, Albert ; Gumming, Paul. / PET studies of net blood-brain clearance of FDOPA to human brain : Age-dependent decline of [18F]fluorodopamine storage capacity. In: Journal of Cerebral Blood Flow and Metabolism. 2005 ; Vol. 25, No. 7. pp. 807-819.
@article{4d151e34e8a741b5a41875dec45c949a,
title = "PET studies of net blood-brain clearance of FDOPA to human brain: Age-dependent decline of [18F]fluorodopamine storage capacity",
abstract = "Conventional methods for the graphical analysis of 6-[18F] fluorodopa (FDOPA)/positron emission tomography (PET) recordings (K inapp) may be prone to negative bias because of oversubtraction of the precursor pool in the region of interest, and because of diffusion of decarboxylated FDOPA metabolites from the brain. These effects may reduce the sensitivity of FDOPA/PET for the detection of age-related changes in dopamine innervations. To test for these biasing effects, we have used a constrained compartmental analysis to calculate the brain concentrations of the plasma metabolite 3-O-methyl-FDOPA (OMFD) during 120 mins of FDOPA circulation in healthy young, healthy elderly, and Parkinson's disease subjects. Calculated brain OMFD concentrations were subtracted frame-by-frame from the dynamic PET recordings, and maps of the FDOPA net influx to brain were calculated assuming irreversible trapping (Kapp). Comparison of Kin app and Kapp maps revealed a global negative bias in the conventional estimates of FDOPA clearance. The present OMFD subtraction method revealed curvature in plots of Kapp at early times, making possible the calculation of the corrected net influx (K) and also the rate constant for diffusion of decarboxylated metabolites from the brain (kloss). The effective distribution volume (EDV2; K/kloss) for FDOPA, an index of dopamine storage capacity in brain, was reduced by 85{\%} in putamen of patients with Parkinson's disease, and by 58{\%} in the healthy elderly relative to the healthy young control subjects. Results of the present study support claims that storage capacity for dopamine in both caudate and putamen is more profoundly impaired in patients with Parkinson's disease than is the capacity for DOPA utilization, calculated by conventional FDOPA net influx plots. The present results furthermore constitute the first demonstration of an abnormality in the cerebral utilization of FDOPA in caudate and putamen as a function of normal aging, which we attribute to loss of vesicular storage capacity.",
keywords = "[F]fluorodopa, Compartmental analysis, Net influx, Parametric mapping, PET",
author = "Yoshitaka Kumakura and Ingo Vernaleken and Gerhard Gr{\"u}nder and Peter Bartenstein and Albert Gjedde and Paul Gumming",
year = "2005",
doi = "10.1038/sj.jcbfm.9600079",
language = "English (US)",
volume = "25",
pages = "807--819",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - PET studies of net blood-brain clearance of FDOPA to human brain

T2 - Age-dependent decline of [18F]fluorodopamine storage capacity

AU - Kumakura, Yoshitaka

AU - Vernaleken, Ingo

AU - Gründer, Gerhard

AU - Bartenstein, Peter

AU - Gjedde, Albert

AU - Gumming, Paul

PY - 2005

Y1 - 2005

N2 - Conventional methods for the graphical analysis of 6-[18F] fluorodopa (FDOPA)/positron emission tomography (PET) recordings (K inapp) may be prone to negative bias because of oversubtraction of the precursor pool in the region of interest, and because of diffusion of decarboxylated FDOPA metabolites from the brain. These effects may reduce the sensitivity of FDOPA/PET for the detection of age-related changes in dopamine innervations. To test for these biasing effects, we have used a constrained compartmental analysis to calculate the brain concentrations of the plasma metabolite 3-O-methyl-FDOPA (OMFD) during 120 mins of FDOPA circulation in healthy young, healthy elderly, and Parkinson's disease subjects. Calculated brain OMFD concentrations were subtracted frame-by-frame from the dynamic PET recordings, and maps of the FDOPA net influx to brain were calculated assuming irreversible trapping (Kapp). Comparison of Kin app and Kapp maps revealed a global negative bias in the conventional estimates of FDOPA clearance. The present OMFD subtraction method revealed curvature in plots of Kapp at early times, making possible the calculation of the corrected net influx (K) and also the rate constant for diffusion of decarboxylated metabolites from the brain (kloss). The effective distribution volume (EDV2; K/kloss) for FDOPA, an index of dopamine storage capacity in brain, was reduced by 85% in putamen of patients with Parkinson's disease, and by 58% in the healthy elderly relative to the healthy young control subjects. Results of the present study support claims that storage capacity for dopamine in both caudate and putamen is more profoundly impaired in patients with Parkinson's disease than is the capacity for DOPA utilization, calculated by conventional FDOPA net influx plots. The present results furthermore constitute the first demonstration of an abnormality in the cerebral utilization of FDOPA in caudate and putamen as a function of normal aging, which we attribute to loss of vesicular storage capacity.

AB - Conventional methods for the graphical analysis of 6-[18F] fluorodopa (FDOPA)/positron emission tomography (PET) recordings (K inapp) may be prone to negative bias because of oversubtraction of the precursor pool in the region of interest, and because of diffusion of decarboxylated FDOPA metabolites from the brain. These effects may reduce the sensitivity of FDOPA/PET for the detection of age-related changes in dopamine innervations. To test for these biasing effects, we have used a constrained compartmental analysis to calculate the brain concentrations of the plasma metabolite 3-O-methyl-FDOPA (OMFD) during 120 mins of FDOPA circulation in healthy young, healthy elderly, and Parkinson's disease subjects. Calculated brain OMFD concentrations were subtracted frame-by-frame from the dynamic PET recordings, and maps of the FDOPA net influx to brain were calculated assuming irreversible trapping (Kapp). Comparison of Kin app and Kapp maps revealed a global negative bias in the conventional estimates of FDOPA clearance. The present OMFD subtraction method revealed curvature in plots of Kapp at early times, making possible the calculation of the corrected net influx (K) and also the rate constant for diffusion of decarboxylated metabolites from the brain (kloss). The effective distribution volume (EDV2; K/kloss) for FDOPA, an index of dopamine storage capacity in brain, was reduced by 85% in putamen of patients with Parkinson's disease, and by 58% in the healthy elderly relative to the healthy young control subjects. Results of the present study support claims that storage capacity for dopamine in both caudate and putamen is more profoundly impaired in patients with Parkinson's disease than is the capacity for DOPA utilization, calculated by conventional FDOPA net influx plots. The present results furthermore constitute the first demonstration of an abnormality in the cerebral utilization of FDOPA in caudate and putamen as a function of normal aging, which we attribute to loss of vesicular storage capacity.

KW - [F]fluorodopa

KW - Compartmental analysis

KW - Net influx

KW - Parametric mapping

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=21344464929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21344464929&partnerID=8YFLogxK

U2 - 10.1038/sj.jcbfm.9600079

DO - 10.1038/sj.jcbfm.9600079

M3 - Article

C2 - 15729292

AN - SCOPUS:21344464929

VL - 25

SP - 807

EP - 819

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 7

ER -